首页RKDA • NASDAQ
add
Arcadia Biosciences Inc
昨日收盘价
$3.48
当日价格范围
$3.35 - $3.51
年度波幅
$1.87 - $10.31
市值
463.94万 USD
平均交易量
5721.00
市盈率
-
股息率
-
主要交易所
NASDAQ
市场资讯
财务信息
损益表
收入
净收入
(USD) | 2024年9月info | 年同比变化 |
---|---|---|
收入 | 153.70万 | 18.41% |
经营支出 | 224.40万 | 20.32% |
净收入 | -161.20万 | 37.20% |
净利润率 | -104.88 | 46.97% |
每股收益 | -0.87 | — |
息税折旧摊销前利润 | -175.30万 | -34.02% |
有效税率 | — | — |
资产负债表
总资产
负债总额
(USD) | 2024年9月info | 年同比变化 |
---|---|---|
现金及短期投资 | 657.60万 | -58.11% |
总资产 | 1524.10万 | -35.05% |
负债总额 | 509.20万 | -36.89% |
权益总额 | 1014.90万 | — |
发行在外的股份 | 136.49万 | — |
市净率 | 0.46 | — |
资产回报率 | -26.99% | — |
资本回报率 | -38.88% | — |
现金流
现金净变动
(USD) | 2024年9月info | 年同比变化 |
---|---|---|
净收入 | -161.20万 | 37.20% |
来自运营的现金 | -175.20万 | 39.27% |
投资现金 | 18.00万 | 3,500.00% |
融资现金 | 4000.00 | -42.86% |
现金净变动 | -156.80万 | 45.42% |
自由现金流 | 325.20万 | 6,857.40% |
简介
Arcadia Biosciences is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation.
It has developed a reduced-gluten and enhanced starch variety of wheat under the name GoodWheat. Arcadia also has a joint venture with Bioceres called Verdeca, which has developed and is commercializing HB4 technology in soybeans that gained FDA approval in 2017. HB4 soybeans have increased yield up to 30% while being more resistant to abiotic stress such as drought. Wikipedia
成立时间
2002
员工数量
21